Viridian Therapeutics, INC.\De (VRDN) SEC Filings — 2024
29 SEC filings for Viridian Therapeutics, INC.\De (VRDN) in 2024.
Filings
- Takeda to Acquire Viridian Therapeutics for $1 Billion — 8-K · Dec 16, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Viridian Therapeutics Files 8-K on Financials — 8-K · Nov 12, 2024
- Viridian Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Fairmount Funds Management Ups Stake in Viridian Therapeutics — SC 13D/A · Sep 17, 2024
- Viridian Therapeutics Enters Material Definitive Agreement — 8-K · Sep 12, 2024
- Shire to Acquire Viridian Therapeutics for $1 Billion — 8-K · Sep 10, 2024
- Viridian Therapeutics Files 8-K on Financials — 8-K · Aug 8, 2024
- Viridian Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Viridian Therapeutics Files 8-K — 8-K · Jul 15, 2024
- Viridian Therapeutics Appoints New CMO, Elects Director — 8-K · Jun 20, 2024
- Viridian Therapeutics Files Proxy Materials — DEFA14A · Jun 10, 2024
- Viridian Therapeutics Files 8-K on Financials — 8-K · May 8, 2024
- Viridian Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Viridian Therapeutics Announces 2024 Annual Meeting of Stockholders on June 17 — DEF 14A · Apr 26, 2024
- Viridian Therapeutics Enters Material Definitive Agreement — 8-K · Apr 16, 2024
- Fairmount Funds Boost Viridian Therapeutics Stake to 15.1% — SC 13D/A · Apr 1, 2024
- Viridian Therapeutics Files 8-K on Financial Condition — 8-K · Feb 27, 2024
- Viridian Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Viridian Therapeutics, INC.\De SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Perceptive Advisors Discloses 5.0% Passive Stake in Viridian Therapeutics — SC 13G · Jan 29, 2024
- BlackRock Amends Viridian Therapeutics Stake, Signals Confidence — SC 13G/A · Jan 29, 2024
- Fairmount Funds Amends Viridian Therapeutics Stake (SC 13D/A) — SC 13D/A · Jan 24, 2024